A Study to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of AZD6615 in Healthy Subjects
Clinical trial NCT04055168 · TERMINATED
Trial details
- NCT number
- NCT04055168
- Sponsor
- AstraZeneca
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2019-07-24
- Primary completion
- 2020-02-10
- Enrollment
- 24
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.